| Authors: |
Pagano G; Roche Pharma Research and Early Development (pRED), Neuroscience and Rare Diseases Discovery and Translational Area, Roche Innovation Center Basel, Basel, Switzerland. gennaro.pagano@roche.com.; University of Exeter Medical School, London, UK. gennaro.pagano@roche.com., Monnet A; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Reyes A; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Ribba B; Roche Pharma Research and Early Development (pRED), Neuroscience and Rare Diseases Discovery and Translational Area, Roche Innovation Center Basel, Basel, Switzerland., Svoboda H; Roche Pharma Research and Early Development (pRED), Neuroscience and Rare Diseases Discovery and Translational Area, Roche Innovation Center Basel, Basel, Switzerland.; Roche Diagnostics GmbH, Penzberg, Germany., Kustermann T; Roche Pharma Research and Early Development (pRED), Neuroscience and Rare Diseases Discovery and Translational Area, Roche Innovation Center Basel, Basel, Switzerland., Simuni T; Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Postuma RB; Department of Neurology, McGill University and Montreal Neurological Institute, Montreal, Quebec, Canada., Pavese N; Clinical Ageing Research Unit, Newcastle University, Newcastle upon Tyne, UK., Stocchi F; University San Raffaele Roma and the Institute for Research and Medical Care, IRCCS San Raffaele Pisana, Rome, Italy., Brockmann K; Hertie Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases (DZNE), University of Tuebingen, Tuebingen, Germany., Smigorski K; Roche Pharma Research and Early Development (pRED), Neuroscience and Rare Diseases Discovery and Translational Area, Roche Innovation Center Basel, Basel, Switzerland., Gerbaldo V; Excelya Germany GmbH, Freiburg, Germany., Fontoura P; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Doody R; F. Hoffmann-La Roche Ltd, Basel, Switzerland.; Genentech USA Inc., San Francisco, CA, USA., Kerchner GA; Roche Pharma Research and Early Development (pRED), Neuroscience and Rare Diseases Discovery and Translational Area, Roche Innovation Center Basel, Basel, Switzerland., Brundin P; Roche Pharma Research and Early Development (pRED), Neuroscience and Rare Diseases Discovery and Translational Area, Roche Innovation Center Basel, Basel, Switzerland., Marek K; Institute for Neurodegenerative Disorders, New Haven, CT, USA., Bonni A; Roche Pharma Research and Early Development (pRED), Neuroscience and Rare Diseases Discovery and Translational Area, Roche Innovation Center Basel, Basel, Switzerland., Nikolcheva T; F. Hoffmann-La Roche Ltd, Basel, Switzerland. |
